Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 11/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 11/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31479670 | 0.83 | HCRTR1 (0.36) | HCRTR1HCRTR2MEN1KMT2AKCNH2 | |
| SCHEMBL31479437 | 0.82 | HCRTR1 (0.37) | HCRTR1HCRTR2MEN1KMT2AKCNH2 | |
| SCHEMBL31479324 | 0.82 | HCRTR1 (0.35) | HCRTR1HCRTR2MEN1KMT2AKCNH2 | |
| SCHEMBL31479897 | 0.81 | HCRTR1 (0.34) | HCRTR1HCRTR2MEN1KMT2AKCNH2 | |
| SCHEMBL31479110 | 0.80 | SLC6A2 (0.35) | HCRTR1HCRTR2 | |
| SCHEMBL31479460 | 0.80 | SLC6A2 (0.35) | HCRTR1HCRTR2 | |
| SCHEMBL31479544 | 0.80 | SLC6A2 (0.35) | HCRTR1HCRTR2 | |
| SCHEMBL31479089 | 0.80 | TSHR (0.41) | MEN1KMT2A | |
| SCHEMBL31479564 | 0.80 | HCRTR1 (0.34) | HCRTR1HCRTR2MEN1KMT2AKCNH2 | |
| SCHEMBL31479275 | 0.79 | HCRTR1 (0.39) | HCRTR1HCRTR2P2RX7S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025067111-A1 | MENIN-MLL INTERACTION INHIBITOR AND PREPARATION METHOD THEREFOR, AND APPLICATION | 苏州必扬医药科技有限公司 | 2025-04-03 | — | — | WO | disclosed |